Jennifer Laffin
,
Credentials
PhD, FACMG
Bio
Laffin joined LMP in January 2023. She was clinical instructor at the University of Wisconsin-Madison, State Laboratory of Hygiene, Division of Disease Prevention- UW Cytogenetic Services and Molecular Genetics. In addition, she was Sr. Laboratory Medical Director for Exact Sciences Laboratories, LLC in Madison. She was also Program Director of the American Board of Medical Genetics and Genomics programs for UW Madison in Clinical Biochemical Genetics, Clinical Cytogenetics and Genomics, Clinical Molecular Genetics and Genomics, and Laboratory Genetics and Genomics from 2015-2019.
Research Summary
Laffin's research interests are in the fields of cytogenetics and molecular diagnostics.
Publications:
Miller-Wilson LA, Rutten LJ, Van Thomme J, Ozbay AB, Laffin J, Limburg P. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a Medicaid population. Preventive Medicine Reports. 2022 Oct 25:102032. doi: 10.1016/j.pmedr.2022.102032
Johnson AM, Dudek JM, Edwards DK, Myers TA, Joseph P, Laffin JJ, Bruinsma JJ. Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma. Expert Rev Mol Diagn. 2021 Nov;21(11):1245-1252. doi: 10.1080/14737159.2021.1981290.
Bhutani G, Astor BC, Mandelbrot DA, Mankowski-Gettle L, Ziemlewicz T, Wells SA, Frater-Rubsam L, Horner V, Boyer C, Laffin J, Djamali A. Long-term outcomes and prognostic factors in kidney transplant recipients with polycystic kidney disease. Kidney360. 2020 Dec 4;2(2):312-324. doi: 10.34067/KID.0001182019.